REFERENCES
- Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol 1998; 103(2)361–364, [PUBMED], [INFOTRIEVE]
- Mourad FH, Hoffbrand AV, Sheikh-Taha M, Koussa S, Khoriaty AI, Taher A. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients. Br J Haematol 2003; 121(1)187–189, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, Burt AD, Fleming KA. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med 1998; 339(7)417–423, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cohen AR, Galanello R, Piga A, De Sanctis V, Tricta F. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood 2003; 102(5)1583–1587, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hoffbrand AV, AL-Refaie F, Davis B, Siritanakatkul N, Jackson BF, Cochrane J, Prescott E, Wonke B. Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients. Blood 1998; 91(1)295–300, [PUBMED], [INFOTRIEVE]
- Cohen AR, Galanello R, Piga A, Dipalma A, Vullo C, Tricta F. Safety profile of the oral iron chelator deferiprone: a multicentre study. Br J Haematol 2000; 108(2)305–312, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Barman Balfour JA, Foster RH. Deferiprone: a review of its clinical potential in iron overload in β‐thalassaemia major and other transfusion-dependent diseases. Drugs 1999; 58(3)553–578, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusional iron overload. Blood 2003; 102(1)17–24, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wanless IR, Sweeney G, Dhillon AP, Guido M, Piga A, Galanello R, Gamberini MR, Schwartz E, Cohen AR. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent β-thalassemia. Blood 2002; 100(5)1566–1569, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1). Transfus Sci 2000; 23(3)211–223, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wu KH, Chang JS, Tsai CH, Peng CT. Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major. Ann Hematol 2004; 83(7)471–473, [PUBMED], [INFOTRIEVE], [CROSSREF]